Wolverine Trading
ENZ

Wolverine Trading’s Enzo Biochem, Inc. ENZ Stock Holding History

Wolverine Trading’s Portfolio ENZ Stock Details ENZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-21,500
Closed -$31K – 5105
2022
Q4 		$31K Buy
+21,500
New +$41.9K ﹤0.01% 3676
2021
Q4 		– Sell
-36,800
Closed -$130K – 7054
2021
Q3 		$130K Sell
36,800
-800
-2% -$2.67K ﹤0.01% 5637
2021
Q2 		$116K Sell
37,600
-40,400
-52% -$127K ﹤0.01% 5329
2021
Q1 		$257K Buy
78,000
+40,400
+107% +$126K ﹤0.01% 4676
2020
Q4 		$98K Buy
37,600
+17,500
+87% +$38.1K ﹤0.01% 4468
2020
Q3 		$42K Sell
20,100
-3,800
-16% -$9.03K ﹤0.01% 4301
2020
Q2 		$54K Buy
+23,900
New +$61.4K ﹤0.01% 4299
2017
Q4 		– Sell
-57,800
Closed -$605K – 5620
2017
Q3 		$605K Buy
+57,800
New +$642K ﹤0.01% 2405

Other funds holding ENZ

HFA
Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
RAM
Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wolverine Trading's ENZ Position: Q1 2023 in Review

Wolverine Trading sold out of Enzo Biochem, Inc. (ENZ) in Q1 2023, closing a stake of 21,266 shares — an estimated $31.6K sold.

Wolverine Trading first reported a position in ENZ in Q3 2017 and held it in 9 quarters. The position peaked at $173K in Q1 2021. 52 funds tracked by Wall St. Rank hold ENZ as of Q1 2023.

  • Wolverine Trading reported no remaining Enzo Biochem, Inc. position as of Q1 2023 after selling out during the quarter.
  • Wolverine Trading sold 21,266 Enzo Biochem, Inc. shares in Q1 2023, an estimated $31.6K.
  • Wolverine Trading first reported a position in Enzo Biochem, Inc. in Q3 2017 and held it in 9 quarters.
  • Wolverine Trading's Enzo Biochem, Inc. position peaked at $173K in Q1 2021.
  • 52 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2023.

Based on Wolverine Trading's 13F filing for Q1 2023, filed 15 May 2023.